Role of GOLPH3 and TPX2 in Neuroblastoma DNA Damage Response and Cell Resistance to Chemotherapy

Por Ognibene, Marzia, Podestà, Marina, Garaventa, Alberto, Pezzolo, Annalisa
Publicado no Int J Mol Sci (2019)

Identification of a minimal region of loss on chromosome 6q27 associated with poor survival of high-risk neuroblastoma patients

Por Ognibene, Marzia, Morini, Martina, Garaventa, Alberto, Podestà, Marina, Pezzolo, Annalisa
Publicado no Cancer Biol Ther (2020)

Brain Metastasis from Neuroblastoma Depicted by (18)F-DOPA PET/CT

Por Piccardo, Arnoldo, Morana, Giovanni, Massollo, Michela, Pescetto, Marco, Conte, Massimo, Garaventa, Alberto
Publicado no Nucl Med Mol Imaging (2015)

Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees

Por Bisogno, Gianni, Soloni, Pietro, Conte, Massimo, Podda, Marta, Ferrari, Andrea, Garaventa, Alberto, Luksch, Roberto, Cecchetto, Giovanni
Publicado em 2012

Paraneoplastic cerebellar ataxia associated with anti-Hu antibodies and benign ganglioneuroma

Por Fancellu, Roberto, Corsini, Elena, Bernardi, Gaetano, Buzzo, Paolo, Ferrari, Maria Luisa, Lamantea, Eleonora, Garaventa, Alberto, Truini, Mauro, Salvarani, Sandro
Publicado no Funct Neurol (2014)

Intratumoral diversity of telomere length in individual neuroblastoma tumors

Por Pezzolo, Annalisa, Pistorio, Angela, Gambini, Claudio, Haupt, Riccardo, Ferraro, Manuela, Erminio, Giovanni, De Bernardi, Bruno, Garaventa, Alberto, Pistoia, Vito
Publicado no Oncotarget (2014)

Transcribed-ultra conserved region expression is associated with outcome in high-risk neuroblastoma

Por Scaruffi, Paola, Stigliani, Sara, Moretti, Stefano, Coco, Simona, De Vecchi, Carla, Valdora, Francesca, Garaventa, Alberto, Bonassi, Stefano, Tonini, Gian Paolo
Publicado em 2009

Logic Learning Machine creates explicit and stable rules stratifying neuroblastoma patients

Por Cangelosi, Davide, Blengio, Fabiola, Versteeg, Rogier, Eggert, Angelika, Garaventa, Alberto, Gambini, Claudio, Conte, Massimo, Eva, Alessandra, Muselli, Marco, Varesio, Luigi
Publicado em 2013

Identification of GALNT14 as a novel neuroblastoma predisposition gene

Por De Mariano, Marilena, Gallesio, Roberta, Chierici, Marco, Furlanello, Cesare, Conte, Massimo, Garaventa, Alberto, Croce, Michela, Ferrini, Silvano, Tonini, Gian Paolo, Longo, Luca
Publicado no Oncotarget (2015)

Hypoxia Predicts Poor Prognosis in Neuroblastoma Patients and Associates with Biological Mechanisms Involved in Telomerase Activation and Tumor Microenvironment Reprogramming

Por Cangelosi, Davide, Morini, Martina, Zanardi, Nicolò, Sementa, Angela Rita, Muselli, Marco, Conte, Massimo, Garaventa, Alberto, Pfeffer, Ulrich, Bosco, Maria Carla, Varesio, Luigi, Eva, Alessandra
Publicado no Cancers (Basel) (2020)

Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma

Por Pezzolo, Annalisa, Sementa, Angela Rita, Lerone, Margherita, Morini, Martina, Ognibene, Marzia, Defferrari, Raffaella, Mazzocco, Katia, Conte, Massimo, Gigliotti, Anna Rita, Garaventa, Alberto, Pistoia, Vito, Varesio, Luigi
Publicado no Cancer Biol Ther (2017)

Ch14.18 antibody produced in CHO cells in relapsed or refractory Stage 4 neuroblastoma patients: A SIOPEN Phase 1 study

Por Ladenstein, Ruth, Weixler, Silke, Baykan, Bianca, Bleeke, Matthias, Kunert, Renate, Katinger, Dietmar, Pribill, Ingrid, Glander, Petra, Bauer, Steffen, Pistoia, Vito, Michon, Jean, Garaventa, Alberto, Lode, Holger N.
Publicado em 2013

CHL1 gene acts as a tumor suppressor in human neuroblastoma

Por Ognibene, Marzia, Pagnan, Gabriella, Marimpietri, Danilo, Cangelosi, Davide, Cilli, Michele, Benedetti, Maria Chiara, Boldrini, Renata, Garaventa, Alberto, Frassoni, Francesco, Eva, Alessandra, Varesio, Luigi, Pistoia, Vito, Pezzolo, Annalisa
Publicado no Oncotarget (2018)

Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma

Por Morandi, Fabio, Amoroso, Loredana, Dondero, Alessandra, Castriconi, Roberta, Parodi, Stefano, Luksch, Roberto, Casale, Fiorina, Castellano, Aurora, Garaventa, Alberto, Moretta, Alessandro, Bottino, Cristina, Ponzoni, Mirco, Corrias, Maria Valeria
Publicado no Oncoimmunology (2018)

Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma

Por Cangemi, Giuliana, Reggiardo, Giorgio, Barco, Sebastiano, Barbagallo, Laura, Conte, Massimo, D’Angelo, Paolo, Bianchi, Maurizio, Favre, Claudio, Galleni, Barbara, Melioli, Giovanni, Haupt, Riccardo, Garaventa, Alberto, Corrias, Maria V
Publicado em 2012

Exosomes from Plasma of Neuroblastoma Patients Contain Doublestranded DNA Reflecting the Mutational Status of Parental Tumor Cells

Por Degli Esposti, Chiara, Iadarola, Barbara, Maestri, Simone, Beltrami, Cristina, Lavezzari, Denise, Morini, Martina, De Marco, Patrizia, Erminio, Giovanni, Garaventa, Alberto, Zara, Federico, Delledonne, Massimo, Ognibene, Marzia, Pezzolo, Annalisa
Publicado no Int J Mol Sci (2021)

Association of PARP1 polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma

Por Avitabile, Marianna, Lasorsa, Vito Alessandro, Cantalupo, Sueva, Cardinale, Antonella, Cimmino, Flora, Montella, Annalaura, Capasso, Dalila, Haupt, Riccardo, Amoroso, Loredana, Garaventa, Alberto, Quattrone, Alessandro, Corrias, Maria Valeria, Iolascon, Achille, Capasso, Mario
Publicado no J Cell Mol Med (2020)

Topotecan-Vincristine-Doxorubicin in Stage 4 High-Risk Neuroblastoma Patients Failing to Achieve a Complete Metastatic Response to Rapid COJEC: A SIOPEN Study

Por Amoroso, Loredana, Erminio, Giovanni, Makin, Guy, Pearson, Andrew D. J., Brock, Penelope, Valteau-Couanet, Dominique, Castel, Victoria, Pasquet, Marlène, Laureys, Genevieve, Thomas, Caroline, Luksch, Roberto, Ladenstein, Ruth, Haupt, Riccardo, Garaventa, Alberto
Publicado no Cancer Res Treat (2018)

Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

Por Siebert, Nikolai, Troschke-Meurer, Sascha, Marx, Madlen, Zumpe, Maxi, Ehlert, Karoline, Gray, Juliet, Garaventa, Alberto, Manzitti, Carla, Ash, Shifra, Klingebiel, Thomas, Beck, James, Castel, Victoria, Valteau-Couanet, Dominique, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Publicado no Cancers (Basel) (2018)

Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD(2) antibody ch14.18/CHO

Por Mueller, Ina, Ehlert, Karoline, Endres, Stefanie, Pill, Lena, Siebert, Nikolai, Kietz, Silke, Brock, Penelope, Garaventa, Alberto, Valteau-Couanet, Dominique, Janzek, Evelyne, Hosten, Norbert, Zinke, Andreas, Barthlen, Winfried, Varol, Emine, Loibner, Hans, Ladenstein, Ruth, Lode, Holger N.
Publicado no MAbs (2017)